1. Home
  2. COKE vs RGEN Comparison

COKE vs RGEN Comparison

Compare COKE & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COKE
  • RGEN
  • Stock Information
  • Founded
  • COKE 1902
  • RGEN 1981
  • Country
  • COKE United States
  • RGEN United States
  • Employees
  • COKE N/A
  • RGEN N/A
  • Industry
  • COKE Beverages (Production/Distribution)
  • RGEN Medical/Dental Instruments
  • Sector
  • COKE Consumer Staples
  • RGEN Health Care
  • Exchange
  • COKE Nasdaq
  • RGEN Nasdaq
  • Market Cap
  • COKE 9.8B
  • RGEN 8.0B
  • IPO Year
  • COKE N/A
  • RGEN N/A
  • Fundamental
  • Price
  • COKE $114.72
  • RGEN $127.06
  • Analyst Decision
  • COKE
  • RGEN Buy
  • Analyst Count
  • COKE 0
  • RGEN 12
  • Target Price
  • COKE N/A
  • RGEN $170.40
  • AVG Volume (30 Days)
  • COKE 729.9K
  • RGEN 722.7K
  • Earning Date
  • COKE 07-30-2025
  • RGEN 07-29-2025
  • Dividend Yield
  • COKE 0.86%
  • RGEN N/A
  • EPS Growth
  • COKE 32.28
  • RGEN N/A
  • EPS
  • COKE 6.42
  • RGEN N/A
  • Revenue
  • COKE $6,888,067,000.00
  • RGEN $650,429,000.00
  • Revenue This Year
  • COKE N/A
  • RGEN $13.93
  • Revenue Next Year
  • COKE N/A
  • RGEN $14.35
  • P/E Ratio
  • COKE $17.38
  • RGEN N/A
  • Revenue Growth
  • COKE 3.21
  • RGEN 4.88
  • 52 Week Low
  • COKE $105.21
  • RGEN $102.97
  • 52 Week High
  • COKE $146.09
  • RGEN $182.52
  • Technical
  • Relative Strength Index (RSI)
  • COKE 58.90
  • RGEN 52.32
  • Support Level
  • COKE $107.21
  • RGEN $121.44
  • Resistance Level
  • COKE $112.56
  • RGEN $126.61
  • Average True Range (ATR)
  • COKE 2.65
  • RGEN 4.65
  • MACD
  • COKE 1.28
  • RGEN 0.34
  • Stochastic Oscillator
  • COKE 91.10
  • RGEN 54.42

About COKE Coca-Cola Consolidated Inc.

Coca-Cola Consolidated Inc distributes, markets and manufactures nonalcoholic beverages. It offer a range of nonalcoholic beverage products and flavors, including both sparkling and still beverages. Sparkling beverages are carbonated beverages and the Company's principal sparkling beverage is Coca Cola. Still beverages include energy products and noncarbonated beverages such as bottled water, ready-to-drink tea, ready-to-drink coffee, enhanced water, juices and sports drinks. The Company has three operating segments: Nonalcoholic Beverages, All Other and Eliminations. key revenue is generated from Nonalcoholic Beverages.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: